Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Omega-6:Omega-3 Fatty Acid Ratio on Delaying Progression of Age-related Macular Degeneration (AMD) in Moderate to High Risk Individuals.

NCT00987129 is registered in ClinicalTrials.gov with Yves Sauve as lead sponsor.

NCT NCT00987129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00987129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Omega-6:Omega-3 Fatty Acid Ratio on Delaying Progression of Age-related Macular Degeneration (AMD) in Moderate to High Risk Individuals.
Lead sponsor
Yves Sauve
Phase
Observational
Overall status
Terminated
Start date
March 31, 2012
Completion date
December 31, 2014
Enrollment
200 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration